Babban nauyin tumor, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H

An yarda da Pembrolizumab don amfani da ita a cikin kowace cutar kansa tare da babban nauyin maye gurbi

Yuli 2021: Hukumar Abinci da Magunguna ta Amurka (FDA) ta faɗaɗa alamun pembrolizumab (Keytruda), maganin rigakafi, don haɗa kowane ciwon daji tare da babban nauyin maye gurbin (TMB-H). Sabuwar izini shine f..

2018 ASCO taron shekara-shekara, Taron ASCO, cetuximab, erbitux, mai da hankali rage, HNSCC, Pabosini

Pabosini da cetuximab don maganin kansar kai da wuya tare da ragin kashi 70%

Dangane da sakamakon da aka sanar a taron shekara-shekara na ASCO na 2018, CDK4 / 6 inhibitors pabociclib (Ibrance) da cetuximab (Erbitux) sun haɗu da jiyya na platinum-resistant da HPV-mai zaman kanta mai maimaitawa / metastatic kai da ne ..

nitrosonornicotine, Shan taba, taba-takamaiman nitrosamines

Dukansu sigarin e-sigari da taba na yau da kullun suna da alaƙa da ciwon daji na baki

A taron na 96 na Associationungiyar International for Dental Research (IADR), Benjamin Chaffee na Jami'ar Kalifoniya, San Francisco ya buga rahoto kan nicotine da carcinogens a cikin taba.

Maganin hanawa na EfB4-ephrin-B2, Sabuwar fasaha

Sabbin hanyoyi don yakar cutar kansar kai da wuya

Ko da tare da tiyata, radiotherapy, chemotherapy, da / ko kwayar cutar da aka yi niyya (kamar cetuximab), ƙimar rayuwa ta shekaru biyar don ci gaban kai da wuya na cikin gida kawai 46% ne. Yawancin lokaci, magani yana da kyau a farkon, amma ..

Man Citrus na iya taimakawa sauƙaƙe alamun bushewar da lalacewa ta hanyar tasirin radiation a kan kai da wuyansa

A cewar wani sabon binciken da Makarantar Medicine ta Jami'ar Stanford ta yi, wani fili wanda aka samu a cikin man citrus na iya taimakawa wajen magance alamomin bushewar baki sakamakon lalacewar cutar kanjamau a cikin kai da wuya kansar. Kwayoyin mai na bawon Citrus sune ..

Nivolumab haɗe tare da ipilimumab shine farkon nasarar nasara don cutar kansa da wuya

A cikin marasa lafiya tare da mummunan ƙwayar melanoma, haɗuwa da ipilimumab (CTLA4 antibody) da kuma shirin mutuwa (PD) -1 mai hana nivolumab na iya inganta yanayin hangen nesa idan aka kwatanta da monotherapy. Dangane da wadannan ..

Ci gaban bincike game da cututtukan kansa da wuyan wuyan wuyansa

Idan aka kwatanta da wasu cututtukan ciwace-ciwacen ƙwayoyin cuta kamar ƙananan ƙwayoyin cuta na huhu (NSCLC) da ciwon nono, kansar kwayar cutar kanjamau (HNSCC) ba ta da yawa a Amurka. Akwai kusan lokuta 500,000 a duk duniya eac ..

Shin marasa lafiya da ke fama da kansar kai da wuya za su ji daɗin tukunyar zafi mai zafi yayin aikin proton?

Mista Xu dan asalin Chongqing ne. Yana da yaji sosai kuma ba shi da farin ciki. Daga cikin dukkan kayan yaji, Chongqing tukunyar zafi mai yaji shine mafi soyuwarsa. Koyaya, cikin rashin sa'a, an sami mummunan ƙwayar cuta tare da glandar parotid, wanda shine ty ..

Maganar PD-L1 a cikin CTC na marasa lafiya da keɓaɓɓen ƙwayoyin ƙwayoyin cuta yana haɗuwa da hangen nesa

Jami'ar Athens Strati A et al. ya ruwaito cewa ko PD-L1 yana da matukar damuwa a cikin ƙwayoyin tumo (CTC) na iya ba da ƙarin bayani mai yiwuwa da mahimmanci game da marasa lafiya tare da kwayar cutar kansa da wuyansa ..

Wadanne abubuwa ne ke shafar aikin tiyatar kansa da wuya? Shin likitocin sun juya zuwa kulawar kwantar da hankali?

Rahoton daga Kershena Liao na kwalejin koyon aikin likitanci na Baylor a Amurka kuma ya fi fahimtar tsarin shugaban likitocin kankara da na wucin gadi da ke tunanin sauya sheka zuwa jinya, wanda zai iya taimakawa wajen inganta wannan hadadden p ..